---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/40283235.md"
description: "The Hong Kong stock market's innovative drug sector as a whole lacks new catalysts and is showing weakness: Innovent Biologics rose slightly today, BeiGene was basically flat, CSPC Pharmaceutical Group fell slightly, and Junshi Biosciences also declined; RemeGen fell more than 4%, making it the biggest decliner today, possibly due to profit-taking from previous accumulated gains."
datetime: "2026-04-29T10:45:18.000Z"
locales:
  - [en](https://longbridge.com/en/topics/40283235.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/40283235.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/40283235.md)
author: "[人间半盏茶](https://longbridge.com/en/profiles/26892850.md)"
---

# The Hong Kong stock market's innovative drug secto…


### Related Stocks

- [01877.HK](https://longbridge.com/en/quote/01877.HK.md)
- [09995.HK](https://longbridge.com/en/quote/09995.HK.md)
- [01801.HK](https://longbridge.com/en/quote/01801.HK.md)
- [06160.HK](https://longbridge.com/en/quote/06160.HK.md)
- [ONC.US](https://longbridge.com/en/quote/ONC.US.md)
- [688180.CN](https://longbridge.com/en/quote/688180.CN.md)
- [688331.CN](https://longbridge.com/en/quote/688331.CN.md)
- [688235.CN](https://longbridge.com/en/quote/688235.CN.md)
- [BGNE.US](https://longbridge.com/en/quote/BGNE.US.md)
- [01093.HK](https://longbridge.com/en/quote/01093.HK.md)